WHOLESALE DRUG DISTRIBUTORS
Summary
Amends the Wholesale Drug Distribution Licensing Act. Defines "virtual wholesale distributor". Provides that every virtual wholesale distributor that engages in virtual drug distribution of prescription drugs shall be licensed by the Department of Financial and Professional Regulation. Provides that a virtual wholesale distributor shall only contract with entities licensed under the Act to take physical possession of prescription drugs if the prescription drugs are being shipped into the State. Sets forth requirements for applicants for a virtual wholesale distributor license. Provides that a virtual wholesale distributor shall ensure that any licensed entity providing distribution services to the virtual wholesale distributor complies with certain requirements. Provides that a virtual wholesale distributor shall not operate out of a location that is a residence or personal dwelling. Makes conforming changes in provisions concerning definitions; unlicensed practice; the expiration of a license; rules and regulations; inspection powers of a pharmacy investigator; restrictions on transactions; wholesaler licensing complaints; violations of the Act; temporary suspension of a license; home rule preemption; and drugs in storage. Makes other changes. Effective immediately.
Bill status
signed
all 5 stages cleared
Introduction
Mar 2026
Committee Review
May 2026
Senate Passage
May 2026
House Passage
May 2026
Signed into Law
Jul 2026
Introduced Mar 26, 2026
Signed Jul 31, 2026
Maddy AI version diff · 2 comparisons
What changed between versions
Engrossed
→
Enrolled
·
2 edits
·
Jul 31, 2026
MINOR
The bill transitioned from its 'Engrossed' version to the final 'Enrolled' version, which is the official text sent to the Governor for signature. The changes are primarily technical, involving the removal of draft headers and page markers while preserving the core legal language regarding drug distribution channels and definitions.
Scope change
No substantive changes to the bill's scope, applicability, or legal requirements were made; the text remains identical except for the removal of versioning metadata.
TECHNICAL
Removed draft headers and page break markers (e.g., 'SB3896 Engrossed') that were present in the working version but are not part of the final law.
Adjusted line breaks and spacing to finalize the formatting of the enrolled bill text.
Floor votes · Senate Mar 26, 2026 · House May 22, 2026
How they voted
45–0
Passed · 13 other
Total votes 58
Mar 26, 2026
D
Democratic39
74% Yea
R
Republican19
84% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
29
Key actions
7
Committee
7
Jul 31, 2026
Signed into law
Governor Approved
upper
May 22, 2026
Upper · Passed
Passed Both Houses
upper
May 22, 2026
Lower · Passed
Third Reading - Short Debate - Passed 099-000-000
lower
May 13, 2026
Lower · Passed
Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000
lower
May 7, 2026
Lower · Passed
Committee Deadline Extended-Rule 9(b) May 15, 2026
lower
Apr 27, 2026
Committee
Assigned to Prescription Drug Affordability & Accessibility Committee
lower
Mar 27, 2026
Committee
Referred to Rules Committee
lower
Mar 26, 2026
Introduced
Arrived in House
lower
Mar 26, 2026
Upper · Passed
Third Reading - Passed; 047-000-000
upper
Mar 5, 2026
Upper · Passed
Do Pass Licensed Activities; 008-000-000
upper
Feb 24, 2026
Committee
Assigned to Licensed Activities
upper
Feb 6, 2026
Committee
Referred to Assignments
upper
2 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 3896
Scope: IL
Hi! I can help you understand SB 3896. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline